We are pleased to announce that Alejandro Avilan Garzon, PhD, doctoral researcher conducting his PhD work at Ypso-Facto, has recently published part of his research in Frontiers in Bioengineering and Biotechnology, in collaboration with our colleague David Pfister.
The study investigates key aspects of monoclonal antibody (mAb) production in CHO batch cultures, combining extracellular and intracellular data to gain a deeper understanding of process dynamics.
This work contributes to our ambition to apply Ypso-Facto’s proven DSP methodology to the optimization of upstream processes.